Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Adcentrx Therapeutics Receives FDA Orphan Drug Designation for ADRX‑0405 in Gastric Cancer
Wednesday, July 09, 2025Adcentrx Therapeutics has received orphan drug designation from the US Food and Drug Administration FDA for its investigational treatment ADRX ADRX is a nextgeneration ADC targeting sixtransmembrane epithelial antigen of the prostate STEAP a protein
Mustang Bio Receives FDA Orphan Drug Designation for MB-101 to Treat Brain Cancers
Tuesday, July 08, 2025Mustang Bio a clinicalstage biopharmaceutical company has been granted Orphan Drug Designation by the US Food and Drug Administration FDA for its investigational therapy MB
Chugai and Gero Partner to Develop New Therapies for Age-Related Diseases
Tuesday, July 08, 2025Chugai Pharmaceutical and Gero have entered into a joint research and licence agreement aimed at developing innovative treatments for agerelated diseases
NextCell Pharma Enters into Collaboration with FUJIFILM Biosciences to Advance Cell Therapy Solutions
Friday, July 04, 2025NextCell Pharma AB has announced a strategic collaboration with FUJIFILM Biosciences aiming to combine their expertise in mesenchymal stromal cells MSCs and life science raw materials
Dizal’s ZEGFROVY® Receives FDA Accelerated Approval as First Oral Therapy for EGFR Exon20ins NSCLC
Thursday, July 03, 2025Dizal has announced that the US Food and Drug Administration FDA has granted accelerated approval for ZEGFROVY sunvozertinib to treat adults with locally advanced or metastatic nonsmall cell lung cancer NSCLC carrying EGFR exon insertion mutations
Regeneron Receives FDA Accelerated Approval for Lynozyfic™ in Relapsed or Refractory Multiple Myeloma
Thursday, July 03, 2025Regeneron Pharmaceuticals has received accelerated approval from the US Food and Drug Administration FDA for Lynozyfic linvoseltamabgcpt a bispecific antibody developed for the treatment of adult patients with relapsed or refractory multiple myeloma...
Jazz Pharmaceuticals Receives Approval for Ziihera® for Advanced HER2-Positive Biliary Tract Cancer
Wednesday, July 02, 2025Jazz Pharmaceuticals has received conditional marketing authorisation from the European Commission EC for Ziihera zanidatamab a bispecific antibody targeting HER for the treatment of adults with unresectable locally
Vertex Receives Approval for ALYFTREK® to Treat Cystic Fibrosis
Wednesday, July 02, 2025Vertex Pharmaceuticals has announced that the European Commission has approved ALYFTREK deutivacaftortezacaftorvanzacaftor a new oncedaily CFTR modulator for the treatment of cystic fibrosis CF
HUTCHMED Receives Approval for ORPATHYS® and TAGRISSO® Combination in Lung Cancer Treatment
Tuesday, July 01, 2025HUTCHMED has received approval from the China National Medical Products Administration NMPA for the combination therapy of ORPATHYS savolitinib and TAGRISSO osimertinib
Takeda Receives Approval for GAMMAGARD LIQUID ERC, a Low-IgA Immunoglobulin Therapy
Tuesday, July 01, 2025Takeda has announced that the US Food and Drug Administration FDA has approved GAMMAGARD LIQUID ERC immune globulin infusion human for use in patients aged two years and above with primary immunodeficiency PI
